Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conducted in accordance with the OECD guideline 401 (adopted 24 February 1987) and in compliance with GLP.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1996
Report date:
1996

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Qualifier:
according to guideline
Guideline:
EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
GLP compliance:
yes (incl. QA statement)
Test type:
fixed dose procedure
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
2-(4-benzoyl-3-hydroxyphenoxy)ethyl 2-methylprop-2-enoate
Cas Number:
16613-04-0
Molecular formula:
C19 H18 O5
IUPAC Name:
2-(4-benzoyl-3-hydroxyphenoxy)ethyl 2-methylprop-2-enoate
Details on test material:
- Name of test material (as cited in study report): ULS-611
- Physical state: cream coloured solid
- Analytical purity: no data
- Impurities (identity and concentrations): no data
- Lot/batch No.: I1608X
- Storage condition of test material: ambient temperature (< 25 °C), under artificial light

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River (UK) Ltd., Margate, Kent, UK
- Age at study initiation: 8-12 weeks
- Weight at study initiation: males: 216-240 g, females: 209-232 g
- Fasting period before study: overnight immediately before dosing
- Housing: by sex in groups up to 5 animals per cage
- Diet (ad libitum): Rat and Mouse Expanded Diet No. 1; Special Diets Services Limited, Witham, Essex, UK
- Water (ad libitum): yes
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-21 °C
- Humidity (%): 46-57 %
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
arachis oil
Details on oral exposure:
VEHICLE (for range-finding-, and main study):
- Concentration in vehicle: 200 mg/ml
- Amount of vehicle (if gavage): 10 ml/kg bw
Doses:
2000 mg/kg bw (for range-finding-, and main study)
No. of animals per sex per dose:
Range-finding study:
1 animal per sex per dose

Main study:
5 animals per sex per dose
Control animals:
no
Details on study design:
RANGE-FINDING STUDY:
- Duration of observation period following administration: 5 days
- Frequency of observations and weighing: The animals were observed for deaths or overt signs of toxicity 0.5, 1, 2 and 4 hours after dosing and subsequently once daily for 5 days. Individual body weights were recorded on the day of dosing to allow calculation of individual treatment volumes.
- No necropsies were performed.

MAIN STUDY:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed for deaths or overt signs of toxicity 0.5, 1, 2 and 4 hours after dosing and subsequently once daily for 14 days. Individual body weights were recorded prior to dosing on day 0 and on days 7 and 14.
- At the end of the study the animals were killed by cervical dislocation.
- Necropsy of survivors performed: yes. Necropsy consisted of external examination and opening of the abdominal and thoratic cavities for examination of major organs; the appearance of any macroscopic abnormalities was recorded; no tissues were retained.

Results and discussion

Preliminary study:
In the range-finding study no deaths or clinical signs of toxicity were observed. Based on this information, a dose level of 2000 mg/kg bw was selected for the main study.
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Mortality:
All animals survived.
Clinical signs:
other: No signs of systemic toxicity were noted during the study.
Gross pathology:
No abnormalities were noted at necropsy.

Any other information on results incl. tables

Table 1: Individual body weight of rats after oral application of 2000 mg/kg bw ULS-611 in the main study

animal number

sex

bodyweight [g] at day

 

 

0

7

14

3 - 0

male

227

270

305

3 - 1

male

225

288

341

3 - 2

male

216

281

343

3 - 3

male

222

287

333

3 - 4

male

240

303

351

4 - 0

female

209

231

253

4 - 1

female

219

240

254

4 - 2

female

215

233

241

4 - 3

female

210

246

253

4 - 4

female

232

248

268

Applicant's summary and conclusion